Skip to content

Insider · CIK 0001237556

FOEHR MATTHEW W

Reports to the SEC for 6 companies · EMERYVILLE, CA

Transactions

50

Companies

6

Filings

6

CIK

0001237556

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-04-07OABIWOmniAb, Inc.S Sale−$28.7K
2026-04-07OABIWOmniAb, Inc.M Exercise/Conversion—
2026-04-07OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2026-02-18OABIWOmniAb, Inc.M Exercise/Conversion—
2026-02-18OABIWOmniAb, Inc.S Sale−$52.7K
2026-02-18OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2026-02-18OABIWOmniAb, Inc. · Restricted Stock UnitsA Award—
2026-02-18OABIWOmniAb, Inc. · Stock OptionA Award—
2026-02-17OABIWOmniAb, Inc.S Sale−$35.3K
2026-02-16OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2026-02-16OABIWOmniAb, Inc.M Exercise/Conversion—
2026-01-02VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-01-02VKTXViking Therapeutics, Inc.A Award—
2026-01-02VKTXViking Therapeutics, Inc.S Sale−$562K
2026-01-02VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2026-01-02VKTXViking Therapeutics, Inc.M Exercise/Conversion+$53.3K
2025-12-08OABIWOmniAb, Inc.S Sale−$26.8K
2025-12-07OABIWOmniAb, Inc.M Exercise/Conversion—
2025-12-07OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-08-26OABIWOmniAb, Inc.A Award+$1M
2025-04-11VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2025-04-11VKTXViking Therapeutics, Inc.M Exercise/Conversion+$166K
2025-04-07OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-04-07OABIWOmniAb, Inc.S Sale−$38.8K
2025-04-07OABIWOmniAb, Inc.M Exercise/Conversion—
2025-02-19OABIWOmniAb, Inc.S Sale−$71.6K
2025-02-18OABIWOmniAb, Inc.S Sale−$51.4K
2025-02-18OABIWOmniAb, Inc. · Restricted Stock UnitsA Award—
2025-02-18OABIWOmniAb, Inc. · Stock Option (right to buy)A Award—
2025-02-16OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-02-16OABIWOmniAb, Inc.M Exercise/Conversion—
2025-02-15OABIWOmniAb, Inc.M Exercise/Conversion—
2025-02-15OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-01-21OABIWOmniAb, Inc.S Sale−$135K
2025-01-17OABIWOmniAb, Inc.A Award—
2025-01-02VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2024-12-09OABIWOmniAb, Inc.S Sale−$56.3K
2024-12-07OABIWOmniAb, Inc.M Exercise/Conversion—
2024-12-07OABIWOmniAb, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2024-11-25OABIWOmniAb, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-11-25OABIWOmniAb, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-11-25OABIWOmniAb, Inc.M Exercise/Conversion+$256K
2024-11-25OABIWOmniAb, Inc.M Exercise/Conversion+$114K
2024-06-27OABIWOmniAb, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-06-27OABIWOmniAb, Inc.M Exercise/Conversion+$68.6K
2024-06-27OABIWOmniAb, Inc.M Exercise/Conversion+$154K
2024-06-27OABIWOmniAb, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-05-24OABIWOmniAb, Inc.P Purchase+$1.06M
2024-04-07OABIWOmniAb, Inc.M Exercise/Conversion—
2024-04-07OABIWOmniAb, Inc.F Tax Payment−$98.1K